Cigna Group CEO Brian C. Evanko Receives Annual Equity Award Grant

Executive Summary

On September 3, 2026, Cigna Group ($CI) filed a Form 4 detailing an equity award granted to Brian C. Evanko, President and Chief Executive Officer. On September 1, 2026, Mr. Evanko received a grant of 3,113 restricted shares of Common Stock and 6,716 stock options under the company's long-term incentive plan.

Key Transaction Details

• Non-Derivative Grant: 3,113 shares of restricted stock awarded at $0 per share. These restricted shares vest in three equal annual installments beginning September 1, 2027.
• Derivative Grant: 6,716 stock options with an exercise price of $281.1325 per share, expiring on September 1, 2037, vesting in three equal annual installments beginning September 1, 2027.
• Post-Transaction Holdings: Following the award, Mr. Evanko directly holds 41,030 shares of common stock. He also holds indirect beneficial ownership of 25,614 shares via a GRAT and approximately 919.58 shares via the company 401(k) plan.

Market & Governance Context

This transaction represents standard executive equity compensation and does not reflect an open-market purchase or sale. Consequently, the trading significance is rated as Low.